Is the Delta Plus Variant (B.1.617.2/AY1) more serious than the Delta Variant?

Authors

  • Mohana Priya Kunasekaran UNSW
  • Danielle Hutchinson Kirby Institute
  • Haley Stone Kirby Institute
  • Xin Chen Kirby Institute
  • Moa Aye Kirby Institute

DOI:

https://doi.org/10.31646/gbio.139

Keywords:

delta plus, COVID-19, genomic surveillance, transmissibility, variants of concern

Abstract

When initially identified, the Delta Plus Variant was flagged as a Variant of Concern and was expected to be equally or possibly more pathogenic than the Delta Variant strain. However, a low proportion of global sequences suggest that Delta Plus has reduced transmissibility. Preliminary data shows that existing vaccines are still effective against Delta Plus variant. Continued surveillance is needed for early identification of more virulent strains of SARS-CoV-2 virus.

Downloads

Published

2021-12-21

How to Cite

Kunasekaran, M. P., Hutchinson, D., Stone, H., Chen, X., & Aye, M. (2021). Is the Delta Plus Variant (B.1.617.2/AY1) more serious than the Delta Variant?. Global Biosecurity, 3(1). https://doi.org/10.31646/gbio.139

Issue

Section

Watching Briefs
Received 2021-11-15
Accepted 2021-12-07
Published 2021-12-21